Cargando…

Empagliflozin reduces Ca/calmodulin‐dependent kinase II activity in isolated ventricular cardiomyocytes

AIMS: The EMPA‐REG OUTCOME study showed reduced mortality and hospitalization due to heart failure (HF) in diabetic patients treated with empagliflozin. Overexpression and Ca(2+)‐dependent activation of Ca(2+)/calmodulin‐dependent kinase II (CaMKII) are hallmarks of HF, leading to contractile dysfun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mustroph, Julian, Wagemann, Olivia, Lücht, Charlotte M., Trum, Maximilian, Hammer, Karin P., Sag, Can Martin, Lebek, Simon, Tarnowski, Daniel, Reinders, Jörg, Perbellini, Filippo, Terracciano, Cesare, Schmid, Christof, Schopka, Simon, Hilker, Michael, Zausig, York, Pabel, Steffen, Sossalla, Samuel T., Schweda, Frank, Maier, Lars S., Wagner, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073019/ https://www.ncbi.nlm.nih.gov/pubmed/30117720 http://dx.doi.org/10.1002/ehf2.12336

Ejemplares similares

Empagliflozin inhibits Na(+)/H(+) exchanger activity in human atrial cardiomyocytes
por: Trum, Maximilian, et al.
Publicado: (2020)

Empagliflozin Inhibits Cardiac Late Sodium Current by Ca/Calmodulin-Dependent Kinase II
por: Mustroph, Julian, et al.
Publicado: (2022)

Enhanced Heart Failure in Redox‐Dead Cys17Ser PKARIα Knock‐In Mice
por: Islam, M. M. Towhidul, et al.
Publicado: (2021)

Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes
por: Pabel, Steffen, et al.
Publicado: (2020)

The oral Ca/calmodulin‐dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure
por: Mustroph, Julian, et al.
Publicado: (2020)

Detrimental proarrhythmogenic interaction of Ca(2+)/calmodulin-dependent protein kinase II and Na(V)1.8 in heart failure
por: Bengel, Philipp, et al.
Publicado: (2021)

Delayed cardiac tamponade after open heart surgery - is supplemental CT imaging reasonable?
por: Floerchinger, Bernhard, et al.
Publicado: (2013)

Impact of cardiopulmonary bypass on acute kidney injury following coronary artery bypass grafting: a matched pair analysis
por: Schopka, Simon, et al.
Publicado: (2014)

Minimizing the risk of perioperative stroke by clampless off-pump bypass surgery: a retrospective observational analysis
por: Hilker, Michael, et al.
Publicado: (2010)

Empagliflozin Reduces Renal Hyperfiltration in Response to Uninephrectomy, but Is Not Nephroprotective in UNx/DOCA/Salt Mouse Models
por: Tauber, Philipp, et al.
Publicado: (2021)

Inhibition of Na(V)1.8 prevents atrial arrhythmogenesis in human and mice
por: Pabel, Steffen, et al.
Publicado: (2020)

Ablation of atrial fibrillation with the Epicor system: a prospective observational trial to evaluate safety and efficacy and predictors of success
por: Schopka, Simon, et al.
Publicado: (2010)

Ibrutinib impairs IGF-1-dependent activation of intracellular Ca handling in isolated mouse ventricular myocytes
por: Tarnowski, Daniel, et al.
Publicado: (2023)

Left ventricular support adjustment to aortic valve opening with analysis of exercise capacity
por: Camboni, Daniele, et al.
Publicado: (2014)

Ethanol-Induced Atrial Fibrillation Results From Late I(Na) and Can Be Prevented by Ranolazine
por: Mustroph, Julian, et al.
Publicado: (2023)

Current Strategies in Cardiovascular Biomaterial Functionalization
por: Schopka, Simon, et al.
Publicado: (2010)

Abnormal P‐wave terminal force in lead V(1) is a marker for atrial electrical dysfunction but not structural remodelling
por: Lebek, Simon, et al.
Publicado: (2021)

SGLT2 Inhibitors and Their Mode of Action in Heart Failure—Has the Mystery Been Unravelled?
por: Pabel, Steffen, et al.
Publicado: (2021)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Pabel, Steffen, et al.
Publicado: (2021)

Complications after transcatheter aortic valve implantation using transfemoral and transapical approach in general anaesthesia
por: Würschinger, Fabian, et al.
Publicado: (2018)

Early-BYRD: alternative early pacing and defibrillation lead replacement avoiding venous puncture
por: Keyser, Andreas, et al.
Publicado: (2018)

The molecular mechanisms associated with the physiological responses to inflammation and oxidative stress in cardiovascular diseases
por: Zhazykbayeva, Saltanat, et al.
Publicado: (2020)

B-Cell lymphoma at the site of pacemaker generator
por: Keyser, Andreas, et al.
Publicado: (2020)

Assessment of Association Between Venous Occlusion and Infection of Cardiac Implantable Electronic Devices
por: Keyser, Andreas, et al.
Publicado: (2021)

Protected complex percutaneous coronary intervention and transcatheter aortic valve replacement using extracorporeal membrane oxygenation in a high-risk frail patient: a case report
por: Kmiec, Lukasz, et al.
Publicado: (2020)

SAR296968, a Novel Selective Na(+)/Ca(2+) Exchanger Inhibitor, Improves Ca(2+) Handling and Contractile Function in Human Atrial Cardiomyocytes
por: Hegner, Philipp, et al.
Publicado: (2022)

Myocardial Slices: an Intermediate Complexity Platform for Translational Cardiovascular Research
por: Watson, Samuel A., et al.
Publicado: (2019)

Calmodulin and Calmodulin Binding Proteins in Dictyostelium: A Primer
por: O’Day, Danton H., et al.
Publicado: (2020)

Calmodulin-dependent and calmodulin-independent glutamate decarboxylases in apple fruit
por: Trobacher, Christopher P, et al.
Publicado: (2013)

The role of calmodulin and calmodulin-dependent protein kinases in the pathogenesis of atherosclerosis
por: Chen, Mei-Fang
Publicado: (2021)

Empagliflozin increases kidney weight due to increased cell size in the proximal tubule S3 segment and the collecting duct
por: Sinha, Frederick, et al.
Publicado: (2023)

An unexpected ferromagnetic foreign body detected during emergency magnetic resonance imaging: a case report
por: Metterlein, Thomas, et al.
Publicado: (2014)

Heterocellularity and Cellular Cross-Talk in the Cardiovascular System
por: Perbellini, Filippo, et al.
Publicado: (2018)

Empagliflozin in type 1 diabetes
por: Mathieu, Chantal, et al.
Publicado: (2019)

Anti-inflammatory potential of Empagliflozin
por: Pirklbauer, Markus
Publicado: (2021)

Drug eruption associated with empagliflozin
por: Yau, Kevin, et al.
Publicado: (2022)

Purification of calmodulin from Chlamydomonas: calmodulin occurs in cell bodies and flagella
Publicado: (1980)

Human Calmodulin Methyltransferase: Expression, Activity on Calmodulin, and Hsp90 Dependence
por: Magen, Sophia, et al.
Publicado: (2012)

Involvement of calmodulin and calmodulin-like proteins in plant responses to abiotic stresses
por: Zeng, Houqing, et al.
Publicado: (2015)

Characterization and Functional Analysis of Calmodulin and Calmodulin-Like Genes in Fragaria vesca
por: Zhang, Kai, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mneallkk7jlm97kdicjsnmculv